Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4

Mostrar otras versiones (1)

The cytotoxic T lymphocyte antigen-4 (CTLA-4)–blocking antibody ipilimumab results in durable responses in metastatic melanoma, though therapeutic benefit has been limited to a fraction of patients. This calls for identification of resistance mechanisms and development of combinatorial strategies. H...

Descripción completa

Detalles Bibliográficos
Autores principales: Holmgaard, Rikke B., Zamarin, Dmitriy, Munn, David H., Wolchok, Jedd D., Allison, James P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3698523/
https://www.ncbi.nlm.nih.gov/pubmed/23752227
http://dx.doi.org/10.1084/jem.20130066

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3698523/
https://www.ncbi.nlm.nih.gov/pubmed/23752227
http://dx.doi.org/10.1084/jem.20130066

Ejemplares similares